Patrizia Mordenti
Overview
Explore the profile of Patrizia Mordenti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavanna L, Citterio C, Bosi C, Vecchia S, Proietto M, Mordenti P
Oncologist
. 2025 Feb;
30(2).
PMID: 39963827
Background: Traveling to healthcare facilities, particularly in the case of patients requiring frequent visits and repeated treatments, such as cancer patients, is associated with substantial carbon dioxide (CO2) emissions. Moreover,...
2.
Cavanna L, Citterio C, Mordenti P, Proietto M, Bosi C, Vecchia S
Medicina (Kaunas)
. 2023 Dec;
59(12).
PMID: 38138224
: The distance to cancer facilities may cause disparities by creating barriers to oncologic diagnosis and treatment, and travel burden may cause time and financial toxicity. : To relieve travel...
3.
Grassi O, Oleari F, Citterio C, Bontini S, Gozzo C, Premoli J, et al.
Recenti Prog Med
. 2022 Nov;
113(11):669-673.
PMID: 36318170
Introduction: Reliable venous access is essential in providing effective care for many patients. Various vascular access devices (VAD) are available, and are placed by a specialized team using ultrasound guidance...
4.
Oleari F, Citterio C, Bontini S, Grassi O, Gozzo C, Premoli J, et al.
Cureus
. 2022 May;
14(4):e24157.
PMID: 35592209
Background Several studies have recommended the use of vascular access in the treatment of COVID-19 patients. However, little is known about the utility and safety of using a peripheral ultrasound-guided...
5.
Ambroggi M, Citterio C, Vecchia S, Riva A, Mordenti P, Cavanna L
Support Care Cancer
. 2022 Jan;
30(4):3225-3231.
PMID: 34977981
Purpose: Little is known about the real impact of the COVID-19 outbreak on the qualitative and quantitative fall-out on the management of cancer patients. Our objective was to provide evidence...
6.
Cavanna L, Citterio C, Di Nunzio C, Zaffignani E, Cremona G, Vecchia S, et al.
Recenti Prog Med
. 2021 Dec;
112(12):785-791.
PMID: 34924573
Introduction: The natural history of cancer has radically changed in the last decade. The burden of travel from patient's residence to health care providers is an important issue that can...
7.
Cavanna L, Citterio C, Biasini C, Madaro S, Bacchetta N, Lis A, et al.
Eur J Cancer
. 2021 Oct;
157:441-449.
PMID: 34601285
Introduction: Patients with cancer are presumed a frail group at high risk of contracting coronavirus disease (COVID-19), and vaccination represents a cornerstone in addressing the COVID-19 pandemic. However, data on...
8.
Cavanna L, Stroppa E, Citterio C, Mordenti P, Di Nunzio C, Peveri S, et al.
Onco Targets Ther
. 2019 May;
12:3077-3085.
PMID: 31118666
Metastatic pancreatic adenocarcinoma has a very poor prognosis. Although irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX) significantly increases survival in advanced pancreatic cancer, compared to employing only gemcitabine (GEM), toxicities have...
9.
Mordenti P, Proietto M, Citterio C, Vecchia S, Cavanna L
Recenti Prog Med
. 2018 Jul;
109(6):337-341.
PMID: 29968863
Introduction: In the field of oncology, we are all stimulated by the desire to improve the lives of patients with cancer; however little data are available about the amount of...
10.
Cavanna L, Seghini P, Di Nunzio C, Orlandi E, Michieletti E, Stroppa E, et al.
Oncol Lett
. 2018 Mar;
15(4):5787-5791.
PMID: 29552209
Central nervous system (CNS) metastases from cancers of the gastrointestinal tract (GIT) are rare, and occur in 0.16-0.69% of patients with gastric or gastro-esophageal (GE) junction cancer. Overexpression of the...